Research and Markets (http://www.researchandmarkets.com/research/tjn996/burns_global) has announced the addition of the "Burns Global Clinical Trials Review, H2, 2013" report to their offering.

This report provides elemental information and data relating to the clinical trials on Burns. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burns.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Burns Therapeutics Clinical Trials

  • MediWound Ltd.
  • Fibrocell Science, Inc.
  • Bayer AG
  • Plethora Solutions Holdings plc
  • Kuros Biosurgery AG
  • Klinikum St. Georg gGmbH
  • HealOr Ltd.
  • Fresenius SE & Co. KGaA
  • Birken AG
  • Baxter International Inc.

Clinical Trial Overview of Top Institutes / Government

  • The University of Texas Medical Branch at Galveston
  • Massachusetts General Hospital
  • Shriners Hospitals for Children
  • U.S. Army Institute of Surgical Research
  • Shiraz University of Medical Sciences
  • National Institute of General Medical Sciences
  • Tehran University of Medical Sciences
  • Association of Dutch Burn Centres
  • Third Military Medical University
  • Johns Hopkins University

For more information visit http://www.researchandmarkets.com/research/tjn996/burns_global

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals